Clinical Trial Update: WFA+M2BP in Evaluation of Portal Hypertension and Clinical Outcome in Patients With Liver Cirrhosis

View source ↗

Summary

This clinical trial update investigates the biomarker WFA+M2BP for evaluating portal hypertension and clinical outcomes in patients with liver cirrhosis; the cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Hypertension

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Portal Hypertension, Cirrhosis | Status: UNKNOWN